6 January 2014 Time-gated cell imaging using long lifetime near-infrared-emitting quantum dots for autofluorescence rejection
Author Affiliations +
Abstract
Fluorescence imaging is a promising technique for the detection of individual cell migration. Its sensitivity is, however, limited by a high tissue autofluorescence and a poor visible light penetration depth. In order to solve this problem, the fluorescence signal peak wavelength should lie in an absorption and diffusion free region and should be distinguishable, either spectrally or temporally, from the autofluorescence background. We present, here, the synthesis and characterization of low toxicity Zn–Cu–In–Se/ZnS core/shell quantum dots. Their fluorescence emission wavelength peaks around 800 nm, where the absorption and scattering of tissues are minimal. They are coated with a new ligand, which yields small, stable, and bright individual probes in the live cell cytoplasm, even 48 h after the labeling. Furthermore, these near-infrared-emitting quantum dots have a long fluorescence lifetime component (around 150 ns) compared to autofluorescence (<5  ns ). Taking the advantage of this property and coupling these probes to a time-gated detection, we demonstrate efficiently the discrimination between the signal and short lifetime fluorescence such as the autofluorescence. This technique is supported by a method we developed, to massively stain cells that preserves the quantum dot stability and brightness for 48 h.
© 2014 Society of Photo-Optical Instrumentation Engineers (SPIE)
Sophie Bouccara, Sophie Bouccara, Alexandra Fragola, Alexandra Fragola, Emerson Giovanelli, Emerson Giovanelli, Gary Sitbon, Gary Sitbon, Nicolas Lequeux, Nicolas Lequeux, Thomas Pons, Thomas Pons, Vincent Loriette, Vincent Loriette, } "Time-gated cell imaging using long lifetime near-infrared-emitting quantum dots for autofluorescence rejection," Journal of Biomedical Optics 19(5), 051208 (6 January 2014). https://doi.org/10.1117/1.JBO.19.5.051208 . Submission:
JOURNAL ARTICLE
8 PAGES


SHARE
Back to Top